Thursday, November 17, 2011
Rhonda Prisby, an assistant professor of kinesiology in the College of Education and Health Professions, is the lead author on an article that could one day influence the treatment of patients with difficult to heal bone fractures and diseases like arthritis.
The article was published in the November issue of the Journal of Bone and Mineral Research, the official publication of the American Society for Bone and Mineral Research.
Dr. Prisby collaborated with French and Canadian scientists on a study of parathyroid hormone or PTH, which is used as a treatment for osteoporosis.
“When we administered PTH intermittently for 15 and 30 days, we saw increases in bone mass just as we expected,” Prisby says. “But bone blood vessel numbers were decreased with PTH. That was the opposite of what we expected.”
Read more about the PTH study.
© 2013 The University of Texas at Arlington. All rights reserved.
Administrative Office:
5th Floor, Hammond Hall, 701 Planetarium Place
Box 19227, Arlington, TX 76019-0227
Phone: 817-272-2591 | Fax: 817-272-2530
